|
Jan 14
|
Acadia Pharmaceuticals: Billion-Dollar Milestone and Global Expansion in 2025
|
|
Jan 14
|
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 14
|
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
|
|
Jan 2
|
Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing
|
|
Dec 30
|
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
|
|
Oct 31
|
ACADIA Pharmaceuticals Inc (ACAD): Worst-Performing Growth Stock in 2024
|
|
Sep 3
|
High Growth Tech Stocks To Watch In September 2024
|
|
Aug 29
|
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options
|
|
Jul 30
|
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 24
|
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
|
|
Jun 21
|
Why Is ACADIA Pharmaceuticals Inc (ACAD) One of the Best Debt Free Halal Stocks According to Hedge Funds?
|
|
May 15
|
Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
|
|
May 11
|
Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
|
|
May 10
|
ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches
|
|
May 10
|
ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 9
|
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
|
|
May 9
|
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
|
|
May 9
|
ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
|
|
May 8
|
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
|
|
May 8
|
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
|